Finding 1240307 (2024-002)

Material Weakness Repeat Finding
Requirement
ABN
Questioned Costs
-
Year
2024
Accepted
2026-10-13
Audit: 414852
Organization: Wellspan Health (PA)
Auditor: KPMG LLP

AI Summary

  • Core Issue: The Company lost $1,736,959 in FEMA funding due to identified duplication of benefits.
  • Impacted Requirements: The analysis used fiscal year-end 2019 results instead of the required calendar year 2019 results.
  • Recommended Follow-Up: Review and adjust financial analysis methods to align with FEMA's requirements to prevent future funding issues.

Finding Text

The Company experienced de-obligations of previously awarded FEMA funding totaling $1,736,959 related to two projects under the Disaster Grants – Public Assistance (Presidentially Declared Disasters) Program (ALN 97.036). The de-obligations resulted from duplication of benefits (DoB) determinations identified during reviews performed by the Homeland Security Operational Analysis Center (HSOAC), operated by the RAND Corporation and acting on behalf of the U.S. Department of Homeland Security and FEMA. The Company performed its duplication of benefit analysis using its fiscal year-end 2019 financial results (July 1, 2018 through June 30, 2019) as the baseline period. FEMA, utilizing HSOAC's standard methodology described in Methods of Assessing Duplication of Benefits with Patient Care Revenue, As Applied by the Federal Emergency Management Agency to Health Care Providers' Public Assistance Claims During the COVID-19 Emergency (December 18, 2024), required the use of calendar year 2019 financial results as the baseline period. Application of FEMA's standard methodology resulted in the determination that previously awarded funding represented a duplication of benefits and led to the de-obligation of grant funding.

Corrective Action Plan

Certain projects within the Disaster Grants – Public Assistance (Presidentially Declared Disasters) program (ALN 97.036) experienced de-obligations resulting from third-party review performed by the Homeland Security Operational Analysis Center (HSOAC), operated by the RAND Corporation and acting on behalf of the Department of Homeland Security. Since WellSpan reports results on a fiscal year basis, WellSpan performed a duplication of benefit analysis for these projects using fiscal year-end 2019 financial results as the baseline pre-COVID year while guidance stated the analysis should be performed on the calendar year basis. WellSpan is in the process of repaying any benefits deemed to be duplicated. Going forward, WellSpan leadership will institute a formal review and approval process of duplication of benefit methodologies to ensure compliance with the regulatory requirements. Contact Person Responsible for Corrective Action: David Rizzuto, Senior Corporate Controller Completed: August 6, 2026

Categories

No categories assigned yet.

Other Findings in this Audit

  • 1240306 2024-001
    Material Weakness Repeat

Programs in Audit

ALN Program Name Expenditures
97.036 DISASTER GRANTS - PUBLIC ASSISTANCE (PRESIDENTIALLY DECLARED DISASTERS) $6.02M
93.696 CERTIFIED COMMUNITY BEHAVIORAL HEALTH CLINIC EXPANSION GRANTS $942,919
93.243 SUBSTANCE ABUSE AND MENTAL HEALTH SERVICES PROJECTS OF REGIONAL AND NATIONAL SIGNIFICANCE $644,234
93.059 TRAINING IN GENERAL, PEDIATRIC, AND PUBLIC HEALTH DENTISTRY $629,855
93.959 BLOCK GRANTS FOR PREVENTION AND TREATMENT OF SUBSTANCE ABUSE $373,798
93.918 GRANTS TO PROVIDE OUTPATIENT EARLY INTERVENTION SERVICES WITH RESPECT TO HIV DISEASE $197,809
93.395 CANCER TREATMENT RESEARCH $132,121
93.217 FAMILY PLANNING SERVICES $57,195
93.866 AGING RESEARCH $25,850
93.103 FOOD AND DRUG ADMINISTRATION RESEARCH $20,000
93.667 SOCIAL SERVICES BLOCK GRANT $18,993
93.304 RACIAL AND ETHNIC APPROACHES TO COMMUNITY HEALTH $18,959
93.113 ENVIRONMENTAL HEALTH $13,711
93.994 MATERNAL AND CHILD HEALTH SERVICES BLOCK GRANT TO THE STATES $7,096
93.853 EXTRAMURAL RESEARCH PROGRAMS IN THE NEUROSCIENCES AND NEUROLOGICAL DISORDERS $5,098
93.840 TRANSLATION AND IMPLEMENTATION SCIENCE RESEARCH FOR HEART, LUNG, BLOOD DISEASES, AND SLEEP DISORDERS $1,000